NCT04480814View on ClinicalTrials.gov

Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood & Primary Tumor in ER+/HER2- MBC

UnknownOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

October 11, 2019

Primary Completion Date

May 11, 2023

Study Completion Date

June 11, 2023

Conditions
Breast Cancer
Interventions
DIAGNOSTIC_TEST

PIK3CA kit

Prospective investigation of clinical samples for evaluation of IVD clinical performance

Trial Locations (4)

11528

Aretaieio University Hospital of Athens, Athens

18547

Metropolital Hospital, Piraeus

68100

University General Hospital of Alexandroupoli, Alexandroupoli

124 62

University General Hospital of Athens Attikon, Athens

Sponsors

Lead Sponsor

Pharmassist Ltd
All Listed Sponsors
collaborator

University of Athens

OTHER

lead

Pharmassist Ltd

INDUSTRY